US Patent 11007186 Methods of treating RBP4 related diseases with triazolopyridines
Patent 11007186 was granted and assigned to Belite Bio on May, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11007186 Methods of treating RBP4 related diseases with triazolopyridines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
